Community and non community-acquired bacteremia: Correlation between empiric antimicrobial therapy and susceptibility of micro organisms isolated during 2007 in the Île-de-France microbiologists network;Anti-infectieux empiriques dans les 24-48 premières heures des bactériémies des patients hospitalisés dans les hôpitaux du groupe des microbiologistes d'île-de-France en 2007

Pathologie Biologie

Volumn 58, Issue 2, 2010, Pages

  Porcheret, H ^a   Barraud, D ^b   Bingen, M ^b   Rabenja, T ^c   Costa, Y ^c   Esteve V ^d   Faibis, F ^e   Demachy, M C ^e   Scanvic, A ^f   Vallee E ^g   Pean Y ^h  

^a Centre Hospitalier d'Aulnay Sous Bois   (France)

^b CENTRE HOSPITALIER DE GONESSE   (France)

^c Centre hospitalier de Lagny Marne la Vallee   (France)

^d Centre Hospitalier General   (France)

^e CENTRE HOSPITALIER DE MEAUX   (France)

^f CENTRE HOSPITALIER VICTOR DUPOUY   (France)

^g CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^h INSTITUT MUTUALISTE MONTSOURIS   (France)

Author keywords

Antibiotic resistance; Antibiotics; Bloodstream infections; Epidemiology

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; OXACILLIN; PRISTINAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TICARCILLIN; TOBRAMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CHILD; COMMUNICABLE DISEASE; CONTROLLED STUDY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; FRANCE; HOSPITAL PATIENT; HUMAN; INFANT; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG UTILIZATION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; FRANCE; HUMANS; INCIDENCE; INFANT; INPATIENTS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; OUTPATIENTS; POPULATION SURVEILLANCE; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; YOUNG ADULT;

EID: 77952093075     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2009.08.001     Document Type: Article

References (17)

1. Fluit A.C., Jones M.E., Schmitz F.J., Acar J., Gupta R., Verhoef J. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clin Infect Dis 2000, 30:454-460.
2. Tortorano A.M., Peman J., Bernhardt H., Klingspor L., Kibbler C.C., Faure O., et al. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004, 23:317-322.
3. Scheckler W.E., Bobula J.A., Beamsley M.B., Hadden S.T. Bloodstream infections in a community hospital: a 25-year follow-up. Infect Control Hosp Epidemiol 2003, 24:936-941.
4. Pfaller M.A., Jones R.N., Doern G.V., Kugler K. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998, 42:1762-1770.
5. Leibovici L., Shraga I., Drucker M., Konigsberger H., Samra Z., Pitlik S.D. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998, 244:379-386.
6. Comité technique national des infections nosocomiales. Ministère de l'Emploi et de la Solidarité. 100 recommandations pour la surveillance et la prévention des infections nosocomiales. 2e ed, 1999.
7. http://www.sfm.asso.fr/.
8. Endimiani A., Tamborini A., Luzzaro F., Lombardi G., Toniolo A. A two-year analysis of risk factors and outcome in patients with bloodstream infection. Jpn J Infect Dis 2003, 56:1-7.
9. Elhanan G., Raz R., Pitlik S.D., Sharir R., Konisberger H., Samra Z., Kennes Y., et al. Bacteraemia in a community and a university hospital. J Antimicrob Chemother 1995, 36:681-695.
10. Decousser J.W., Pina P., Picot F., Delalande C., Pangon B., Courvalin P., et al. Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey. J Antimicrob Chemother 2003, 51:1213-1222.
11. Marchaim D., Zaidenstein R., Lazarovitch T., Karpuch Y., Ziv T., Weinberger M. Epidemiology of bacteremia episodes in a single center: increase in Gram-negative isolates, antibiotics resistance, and patient age. Eur J Clin Microbiol Infect Dis 2008, 27:1045-1051.
12. Tumbarello M., Sanguinetti M., Montuori E., Trecarichi E.M., Posteraro B., Fiori B., et al. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 2007, 51:1987-1994.
13. Gómez J., García-Vázquez E., Baños R., Canteras M., Ruiz J., Baños V., et al. Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy. Eur J Clin Microbiol Infect Dis 2007, 26:239-245.
14. Micek S.T., Lloyd A.F., Ritchie D.J., Reichley R.M., Fraser V.J., Kollef M.H. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother 2005, 49:1306-1311.
15. Ibrahim E.H., Sherman G., Ward S., Fraser V.J., Kollef M.H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118:146-155.
16. Fraser A., Paul M., Almanasreh N., Tacconelli E., Frank U., Cauda R., et al. Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay. Am J Med 2006, 119:970-976.
17. Marschall J., Agniel D., Fraser V.J., Doherty J., Warren D.K. Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes. J Antimicrob Chemother 2008, 61:1376-1383.